Long-Term Predictors of Mortality After Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents

Grants

Funding Acknowledgements

The Melbourne Interventional Group acknowledges unrestricted educational grant funding from Abbott Vascular, Abbott Australasia Pty Ltd, Pharmaceuticals, Nutritionals and EAS, NSW, Australia, Astra-Zeneca, NSW, Australia, Biotronik, NSW, Australia, Boston-Scientific, NSW, Australia, Bristol-Myers Squibb, Victoria, Australia, CSL, Victoria, Australia, Johnson & Johnson, NSW, Australia, Medtronic, Melbourne, Australia, Pfizer, NSW, Australia, Schering-Plough, NSW, Australia, Sanofi-Aventis, NSW, Australia, Servier, Victoria, Australia. Dr. Dufty's work is supported by a grant from the National Health and Medical Research Council of Australia.